0001572426-16-000162.txt : 20160301
0001572426-16-000162.hdr.sgml : 20160301
20160301140026
ACCESSION NUMBER: 0001572426-16-000162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160225
FILED AS OF DATE: 20160301
DATE AS OF CHANGE: 20160301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GEARING DAVID
CENTRAL INDEX KEY: 0001632481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 161472558
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC
STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-02-25
0001618561
Nexvet Biopharma plc
NVET
0001632481
GEARING DAVID
C/O NEXVET BIOPHARMA PLC
UNIT 5, SRAGH TECHNOLOGY PARK, RAHAN RD
TULLAMORE
L2
R35 FR98
IRELAND
0
1
0
0
Chief Scientific Officer
Ordinary Shares
2016-02-25
4
P
0
19000
3.30
A
102664
I
By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C>
Ordinary Shares
2016-02-26
4
P
0
12126
3.34
A
114790
I
By DJGearing Pty Ltd <Gearing Family Superannuation Fund A/C>
Ordinary Shares
279330
I
By Gearing Family Pty Ltd <Gearing FamilyA/C>
Ordinary Shares
5600
D
The reporting person and his spouse have shared voting and dispositive power with respect to these reported securities.
Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.35, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ David Gearing by Geraldine Farrell, Attorney-in-Fact
2016-02-29